Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
jeudi, octobre 29
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Microbot Medical Inc
MBOT
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$1.11
-0.0103
-0.92%
Dern. MÀJ: Oct 29, 11:47 AM
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Microbot Medical Financials
Microbot Medical (MBOT) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Microbot Medical Q2 EPS $(0.08), Inline, Sales $241.000K Miss $340.000K Estimate
Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.10) per share from the same period last year. The
Benzinga Newsdesk
PRO
Microbot Medical Q4 EPS $(0.04) Beats $(0.06) Estimate
Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 78.95 percent increase over losses of $(0.19) per share from
Benzinga Newsdesk
PRO
Microbot Medical Q2 EPS $(0.10) Misses $(0.08) Estimate
Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.08) by 25 percent. This is a 41.18 percent increase over losses of $(0.17) per share from
Benzinga Newsdesk
Microbot Medical Gets Quality Certification for its System
Microbot Medical Inc. (NASDAQ: MBOT) recently announced the receipt of ISO 13485:2016 certification for its quality management system.
Zacks
Dow Dips Over 300 Points; GameStop Shares Spike Higher
Avi Kapoor
Crude Oil Down Over 3%; US Construction Spending Falls In May
Avi Kapoor
